Alnylam Pharmaceuticals – Investors and Politicians Who Own It
ALNY, 2 share classes and securities
Investors who own it
4 tracked investors, $926.7M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Dodge & CoxQ2 2026 | $588.6M | 0.31% |
David KroinDeep Track Capital, Q2 2026 | $248.3M | 3.61% |
| $59.7M | 0.04% | |
Ray DalioBridgewater Associates, Q2 2026 | $30M | 0.12% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Sold out | 0 |
| Behzad Aghazadeh | Sold out | 0 |
| Dodge & Cox | Reduced −4.2% | 3,622,535 |
| Howard MarksBond | New | 1,800,000 |
| Ray Dalio | New | 2,002 |
| Daniel Schneeberger | Sold out | 0 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Jefferson ShreveR-IN · House | Sold$15K–$50K | May 12, 2025disclosed Jun 22, 2025 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Jan 29, 2024disclosed Feb 15, 2024 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Jan 11, 2024disclosed Feb 15, 2024 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Dec 11, 2023disclosed Jan 7, 2024 |
Daniel S. GoldmanD-NY · House | Bought$15K–$50K | Mar 6, 2023disclosed Apr 17, 2023 |
Daniel S. GoldmanD-NY · House | Sold$15K–$50K | Jan 31, 2023disclosed Feb 24, 2023 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Sep 28, 2022disclosed Oct 16, 2022 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Nov 13, 2020disclosed Dec 9, 2020 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Apr 6, 2020disclosed May 13, 2020 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Oct 18, 2018disclosed Nov 16, 2018 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Jun 1, 2018disclosed Oct 2, 2018 |